Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.700
-0.170 (-5.92%)
Nov 21, 2024, 4:00 PM EST - Market closed
Intensity Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 2.78 | 8.56 | 1.31 | 4.54 | 9.32 | 3.83 |
Short-Term Investments | - | 6.22 | - | - | - | 4.56 |
Cash & Short-Term Investments | 2.78 | 14.78 | 1.31 | 4.54 | 9.32 | 8.39 |
Cash Growth | -82.22% | 1026.22% | -71.10% | -51.28% | 10.99% | - |
Other Receivables | - | - | - | 0.05 | 0.05 | 0.02 |
Receivables | - | - | - | 0.05 | 0.05 | 0.02 |
Prepaid Expenses | 1.01 | 0.68 | 0.06 | 0.07 | 0.07 | 0.06 |
Other Current Assets | - | 0.01 | 0.08 | 0.07 | 0.05 | 0.18 |
Total Current Assets | 3.79 | 15.46 | 1.45 | 4.73 | 9.48 | 8.65 |
Property, Plant & Equipment | 0.13 | 0.15 | 0.14 | 0.32 | 0.49 | 0.25 |
Other Long-Term Assets | 1.3 | 1.68 | 0.17 | 0.17 | 0.18 | 0.03 |
Total Assets | 5.21 | 17.3 | 1.76 | 5.22 | 10.15 | 8.93 |
Accounts Payable | 0.54 | 3.05 | 0.6 | 0.17 | 0.22 | 0.39 |
Accrued Expenses | 1.75 | 0.45 | 0.33 | 0.34 | 0.25 | 0.62 |
Short-Term Debt | - | - | 4.35 | 2.02 | - | - |
Current Portion of Leases | 0.03 | 0.02 | 0.14 | 0.18 | 0.17 | 0.12 |
Other Current Liabilities | - | 0.44 | 1.39 | 1.01 | 0.71 | - |
Total Current Liabilities | 2.32 | 3.96 | 6.82 | 3.72 | 1.35 | 1.13 |
Long-Term Leases | 0.12 | 0.14 | - | 0.14 | 0.33 | 0.14 |
Other Long-Term Liabilities | - | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Total Liabilities | 2.43 | 4.13 | 6.86 | 3.9 | 1.71 | 1.31 |
Common Stock | 0 | 0 | - | 0 | 0 | 0 |
Additional Paid-In Capital | 66.38 | 63.68 | 23.56 | 22.39 | 21.67 | 14.84 |
Retained Earnings | -63.6 | -50.52 | -38.65 | -31.07 | -23.18 | -17.15 |
Comprehensive Income & Other | - | - | - | - | -0.05 | -0.08 |
Total Common Equity | 2.78 | 13.16 | -15.1 | -8.68 | -1.56 | -2.38 |
Shareholders' Equity | 2.78 | 13.16 | -5.1 | 1.32 | 8.44 | 7.62 |
Total Liabilities & Equity | 5.21 | 17.3 | 1.76 | 5.22 | 10.15 | 8.93 |
Total Debt | 0.15 | 0.16 | 4.49 | 2.34 | 0.5 | 0.26 |
Net Cash (Debt) | 2.64 | 14.62 | -3.18 | 2.2 | 8.82 | 8.13 |
Net Cash Growth | -82.98% | - | - | -75.09% | 8.42% | - |
Net Cash Per Share | 0.19 | 1.70 | -0.93 | 0.64 | 2.59 | 2.39 |
Filing Date Shares Outstanding | 13.87 | 13.71 | 3.41 | 3.41 | 3.41 | 3.4 |
Total Common Shares Outstanding | 13.86 | 13.71 | 3.41 | 3.41 | 3.41 | 3.4 |
Working Capital | 1.47 | 11.51 | -5.37 | 1.01 | 8.13 | 7.52 |
Book Value Per Share | 0.20 | 0.96 | -4.43 | -2.55 | -0.46 | -0.70 |
Tangible Book Value | 2.78 | 13.16 | -15.1 | -8.68 | -1.56 | -2.38 |
Tangible Book Value Per Share | 0.20 | 0.96 | -4.43 | -2.55 | -0.46 | -0.70 |
Source: S&P Capital IQ. Standard template. Financial Sources.